To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion. 'Johnson & Johnson', 'Merck & Co.', 'Pfizer Inc.', 'Cipla Limited', 'Dr. Reddy's Laboratories Ltd.', 'Sun Pharmaceutical Industries Ltd.', 'GlaxoSmithKline plc', 'Aclaris Therapeutics, Inc.', 'Concert Pharmaceuticals, Inc.', 'HCell Inc.', 'Follica, Inc.', 'Histogen Inc.', 'Allergan plc', 'Bayer AG', 'Kythera Biopharmaceuticals, Inc.', 'Polichem S.A.', 'Takeda Pharmaceutical Company Limited', 'Almirall, S.A.', 'Perrigo Company plc', 'Vegalab, Inc.'

The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2021. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

Feedback From Our Clients

Global Alopecia Market

Product ID: SQSG35I2021

$5,300
BUY NOW